Manisha Balwani, MD
Enriched profileProfessor, Department of Genetics and Genomic Sciences and Department of Medicine; Chief, Division of Medical Genetics and Genomics · Icahn School of Medicine at Mount Sinai
Manisha Balwani is Professor, Department of Genetics and Genomic Sciences and Department of Medicine; Chief, Division of Medical Genetics and Genomics at Icahn School of Medicine at Mount Sinai. OpenAlex indexes 397 publications with 6,309 citations (h-index 41); ClinicalTrials.gov lists 2 registered studies with this person as an investigator.
Data verified 11 Oct 2026
Overview
Updated 13 Oct 2026
Manisha Balwani, M.D., M.S., is Professor, Department of Genetics and Genomic Sciences and Department of Medicine at Icahn School of Medicine at Mount Sinai. The public record shows 397 publications with 6,309 citations (h-index 41), centered on Metabolism and Genetic Disorders, Lysosomal Storage Disorders Research, Glycogen Storage Diseases and Myoclonus. It also documents an investigator role on 2 registered clinical trials, industry payments reported by 8 companies, 6 NIH-funded awards (2007–2026).
- Top research focus: Metabolism and Genetic Disorders
- 2 registered trials on ClinicalTrials.gov
- Open Payments reporting from 8 companies
Generated from the cited public record · current as of 13 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 16 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 90.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 13 Oct 2026
Listed as an investigator on 2 registered studies on ClinicalTrials.gov. The most recent:
- Oral Iron for Erythropoietic Protoporphyrias
Sponsor: Icahn School of Medicine at Mount Sinai
- Erythropoietic Protoporphyrias: Studies of the Natural History, Genotype-Phenotype Correlations, and Psychosocial Impact
Sponsor: Icahn School of Medicine at Mount Sinai
Industry payments
Updated 13 Oct 2026
8 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- RECORDATI_RARE_DISEASES_INC.Program year20254 payments$14,967openpaymentsdata.cms.gov ↗
- GENZYME CORPORATIONProgram year20256 payments$10,978openpaymentsdata.cms.gov ↗
- Alnylam Pharmaceuticals Inc.Program year20255 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
100%Hydrolytic Lysosomal Glucocerebroside-specific Enzyme100%Vpriv100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 13 Oct 2026
6 NIH research awards on record, funded 2007–2026 per NIH RePORTER. The latest:
- Mount Sinai Center for Undiagnosed Diseases
Icahn School of Medicine at Mount Sinai
FY2026$810,454U01NS139213 - Using electronic medical record data to shorten diagnostic odysseys for rare genetic disorders in children and adults in two New York City health care settings
Icahn School of Medicine at Mount Sinai
FY2026$473,116UH3TR004040 - Mount Sinai Center for Undiagnosed Diseases
Icahn School of Medicine at Mount Sinai
FY2025$816,633U01NS139213
Congress activity
Updated 13 Oct 2026
6 congress contributions (2020–2024) across AACR, ASH per OpenAlex. The most recent:
- Abstract 4807: Gaucher disease treatment reduces the progression of smoldering myeloma
AACR Annual Meeting
AACR2024Co-author - Enhanced Detection of Pathogenic Germline Variants in Plasma Cell Disorders: Impact of a Targeted Genetic Counseling Referral Pathway
ASH Annual Meeting
ASH2024Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Evidence-based consensus guidelines for the diagnosis and management of erythropoietic protoporphyria and X-linked protoporphyria
Journal of the American Academy of Dermatology
2022
Most-cited works
by citation count (OpenAlex)- 01Phase 3 Trial of RNAi Therapeutic Givosiran for Acute Intermittent PorphyriaArticle608 citations2020
- 02Afamelanotide for Erythropoietic ProtoporphyriaArticle286 citations2015
- 03Phase 1 Trial of an RNA Interference Therapy for Acute Intermittent PorphyriaArticle259 citations2019
- 04The porphyrias: advances in diagnosis and treatmentArticle259 citations2012
- 05A Phase 3 Trial of Sebelipase Alfa in Lysosomal Acid Lipase DeficiencyArticle249 citations2015
Network
Updated 13 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 13 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Mentions by others
where others cite or feature them- Other
porphyriafoundation.org/news-blog/all-news/givlaari-givosarin-zoom-informational
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →porphyriafoundation.org ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 13 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- M.D.
University of Bombay
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.icahn.mssm.edu ↗ - M.S. in Genetics
University of Pittsburgh
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.icahn.mssm.edu ↗
Editorial & leadership roles
journal and society appointments- Scientific Advisory Board member
American Porphyria Foundation
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →porphyriafoundation.org ↗
Secondary affiliations
appointments beyond the home institution- Director
Lysosomal Disease Program, Mount Sinai
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.icahn.mssm.edu ↗ - Faculty member
Icahn Genomics Institute
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.icahn.mssm.edu ↗ - Investigator
NIH Rare Diseases Clinical Research Network Porphyrias Consortium
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.icahn.mssm.edu ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Jonathan Halperin, MD
Icahn School of Medicine at Mount Sinai
Fred Lublin, MD
Icahn School of Medicine at Mount Sinai
Sundar Jagannath, MD
Icahn School of Medicine at Mount Sinai
Ronald Wapner, MD
Columbia University Irving Medical Center
Virginia Kimonis, MD
UC Irvine School of Medicine
Robert Hopkin, MD
Cincinnati Children's Hospital Medical Center
Nicola Longo, MD
University of California, Los Angeles